Viking data provide latest test of oral obesity drug potential

Viking data provide latest test of oral obesity drug potential

Source: 
BioPharma Dive
snippet: 

Results from a small study showed Viking’s therapy led to competitive rates of weight loss over four weeks with fewer side effects than some would-be rivals.